Utilization of Subcutaneous Cardioverter-Defibrillator in Poland and Europe-Comparison of the Results of Multi-Center Registries.

Int J Environ Res Public Health · 2021 · PMC8297309 · PMID 34281115

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Furthermore, in the European group S-ICD was slightly more frequently implanted in patients without structural heart disease, but that comparison did not reach statistical significance (29.4% vs. 18.3%).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.